|Articles|December 1, 1996

November/December 1996
Volume 2
Issue 11

A Pharmacoeconomic Assessment of Torsemide in the Treatment of Congestive Heart Failure

Author(s)Alan H. Heaton, PharmD, Jeffrey P. Trotter, MM

Download PDF: A Pharmacoeconomic Assessment of Torsemide in the Treatment of Congestive Heart Failure

Articles in this issue

over 29 years ago

Article

The Year in Review

over 29 years ago

Article

Coverage Decisions for Medical Technology by Managed Care: Relationship to Organizational and Physician Payment Characteristics

over 29 years ago

Article

Childhood Immunizations: Beyond HEDIS

over 29 years ago

Article

Implementation of a Clinical Pathway for Cesarean Section

over 29 years ago

Article

Six HMOs in Search of a Study: Comments on Two Papers by Horn et al

over 29 years ago

Article

Homecare Therapy: A Cost-Effective Alternative Approach to the Management of Advanced Heart Failure

over 29 years ago

Article

The Cholesterol Population Model: US Population Requirements for Treatment of Hypercholesterolemia

over 29 years ago

Article

The Economic and Health-Related Quality of Life Impact of Epilepsy

over 29 years ago

Article

Telecomputing as a Tool to Increase Consumer Participation in Managed Care

over 29 years ago

Article

Impact of Oral Sumatriptan on Workplace Productivity, Health-Related Quality of Life, Healthcare Use, and Patient Satisfaction with Medication in Nurses with Migraine

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

Social Needs Screening and Supplemental Benefits in Medicare Advantage

ByJessica I. Billig, MD, MSc,Michael D. Dang, MS,Jennifer R. Cardin, MSc,Joseph H. Joo, MD, MS,Joshua M. Liao, MD, MSc

June 3rd 2026

Availability of Hospital Financial Assistance Documents in Non-English Languages

ByNina Linh Nguyen, MHA,Samantha Randall, BA,Ella Cho,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

June 3rd 2026

Man having heart attack | Image Credit: © dragonstock - stock.adobe.com

Experts Sound Alarm on Underrecognized Heart Failure Subtype as Costs, Readmissions Soar

ByChristina Mattina

June 2nd 2026

Doctor and patient with obesity | Image Credit: © Studio Romantic - stock.adobe.com

Clinicians Grapple With Barriers to Multidisciplinary Obesity Treatment

ByChristina Mattina

June 2nd 2026

A Pharmacoeconomic Assessment of Torsemide in the Treatment of Congestive Heart Failure

Articles in this issue

Related Content

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

Social Needs Screening and Supplemental Benefits in Medicare Advantage

Availability of Hospital Financial Assistance Documents in Non-English Languages

Experts Sound Alarm on Underrecognized Heart Failure Subtype as Costs, Readmissions Soar

Clinicians Grapple With Barriers to Multidisciplinary Obesity Treatment

Trending on AJMC

Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home

Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

CAR T Therapy Likely the Next Frontier for Treating Patients With MG: James F. Howard, MD